Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
Abstract Background Currently, immunotherapy is widely used in the treatment of various stages of non-small cell lung cancer. According to clinical experience and results of previous studies, immunotherapy as neoadjuvant therapy seems to exhibit better efficacy against early resectable non-small cel...
Main Authors: | Yimin Wang, Chuling Li, Zimu Wang, Zhaofeng Wang, Ranpu Wu, Ying Wu, Yong Song, Hongbing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-022-02580-1 |
Similar Items
-
Immunotherapy for small-cell lung cancer
by: A. Ye. Kuzminov, et al.
Published: (2019-06-01) -
PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
by: A. V. Rudakova, et al.
Published: (2017-08-01) -
Chemotherapy: A partnership with immunotherapy in non‐small cell lung cancer
by: Ana Sofia Mendes, et al.
Published: (2023-02-01) -
Clinical Progress in the Immunotherapy of Small Cell Lung Cancer
by: Weiwei WANG, et al.
Published: (2022-06-01) -
The advances in immunotherapy biomarkers of small cell lung cancer
by: XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia
Published: (2021-07-01)